Prevalencia de síntomas depresivos y diagnóstico de sospecha de depresión en pacientes con EPOC

Barrueco-Otero, Enrique; Matellán, Belén Refoyo; Puente, Javier Martín; Mañes, Clara Viñado; Subías, Erica León; Pueyo, Javier Olivera; Sánchez, Consuelo Sancho

doi:10.1016/j.aprim.2021.102236

Cited by 6 publications

(4 citation statements)

References 26 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results contrast with those observed by our research group in relation to depression [15], in which the number of personal factors that showed influence included age and living alone. Additionally, other aspects related to the disease itself, such as the CAT score, BODEx index, degree of bronchial obstruction, phenotype, and risk factor (GesEPOC), as well as GOLD classification grades C and D, also showed significance.…”

Section: Discussioncontrasting

confidence: 99%

“…The prevalence observed in our study, using the HADS test and setting the scale cut-off point at ≥8, was 28.9%, with a total of 85 patients scoring eight points or higher. This is close to the prevalence found by González-Gutiérrez et al [24] with a population group similar to ours [15]. It is noteworthy that in our study only 27 patients (9.2%) had an established anxiety diagnosis, leading to the conclusion that there was significant underdiagnosis in the studied population.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Prevalence of Anxiety in COPD Patients. Usefulness of the HADS Test for Establishing the Diagnostic Suspicion of Anxiety Through the Collaboration Between Primary Care, Pulmonology, and Psychiatry Services

Barrueco,

HERNÁNDEZ-MEZQUITA,

HIDALGO-SIERRA

et al. 2024

Preprint

View full text Add to dashboard Cite

Anxiety disorders, characterized by excessive fear and anxiety, are increasingly recognized as significant comorbidities in chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD). This study aimed to evaluate the prevalence of anxiety in COPD patients referred from primary care centers to pulmonology services and identify predictive factors for anxiety. Conducted as a multicentric, observational, and prospective study, 293 COPD patients were recruited, undergoing comprehensive respiratory and smoking histories, spirometry, and anxiety assessments using the Hospital Anxiety and Depression Scale (HADS). These results show: a diagnosis of suspected anxiety in in 85 patients (29.0%): 17 possible and 68 with a strong suspicion. The study found significant associations between anxiety and factors such as gender (women showed a risk 3.5 times higher than men), weight, and body mass index (BMI). Disease severity, smoking status, and clinical manifestations did not significantly influence anxiety prevalence. The findings underscore the need for systematic psychological evaluations in COPD management, advocating for the use of simple diagnostic tools like the HADS to facilitate referrals to mental health services. Addressing anxiety in COPD patients could potentially improve their quality of life and disease outcomes. The study highlights the importance of a multidisciplinary approach involving family medicine, pulmonology, and psychiatry to optimize COPD patient care and suggests future research should focus on the impact of anxiety treatment on COPD progression. These insights call for integrating psychological assessments into routine clinical practice for comprehensive COPD management.

show abstract

Section: Discussioncontrasting

confidence: 99%

Section: Discussionsupporting

confidence: 91%

Prevalence of Anxiety in COPD Patients. Usefulness of the HADS Test for Establishing the Diagnostic Suspicion of Anxiety Through the Collaboration Between Primary Care, Pulmonology, and Psychiatry Services

Barrueco,

HERNÁNDEZ-MEZQUITA,

HIDALGO-SIERRA

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…The results of this study show that the incidence of anxiety and depression in female patients with COPD is significantly higher than that in male patients, which is consistent with the results of most studies [8] [9]. Women are more sensitive and easily affected by their own and external factors, so the incidence of depression and anxiety is higher.…”

Section: Discussionsupporting

confidence: 90%

Anxiety, Depression and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

Li¹,

Xiang²,

Wang³

et al. 2023

JBM

View full text Add to dashboard Cite

Background: Chronic Obstructive Pulmonary Disease (COPD) is a common and frequently occurring disease, which not only has a higher fatality rate, but also leads to loss of labor force and an obvious decrease in the quality of life in the course of long-term disease, patients with chronic obstructive pulmonary disease complicated with anxiety and depression are a major public health problem. Objective: To investigate the status of anxiety, depression and quality of life and related factors in patients with COPD. Methods: One hundred patients admitted to the Department of Respiratory and Critical Care Medicine of the First Affiliated Hospital of Dali University with chronic obstructive pulmonary disease evaluated by anxiety self-assessment scale, depression self-assessment scale and quality of life rating scale for patients with chronic obstructive pulmonary disease. Results: The incidence of anxiety in COPD patients was 82.5%, and the incidence of depression was 87.3%. The probability of both anxiety and depression was high, and the prevalence of women was significantly higher than that of men. Correlation analysis and logistic regression results showed that education level was negatively correlated with the occurrence of anxiety, and age was positively correlated with the occurrence of anxiety. Elderly patients were prone to anxiety and had lower quality of life. Conclusion: The older and less educated the COPD patients are, the higher the incidence of anxiety and depression, and the higher the incidence in female patients.

show abstract

“…In addition, severe comorbidities may have an impact on COPD morbidity and mortality. The most common comorbidities of COPD include cardiovascular disease, metabolic disorders, osteoporosis, skeletal muscle dysfunction, anxiety/depression, cognitive impairment [4] .Depression is a common complication in patients with COPD [5] .A increasing of prognostic research suggests that mental health problems also signi cantly increase the risk of death from COPD [6] . Depression is a particularly strong predictor of COPD mortality [7] , so it is important to further develop personalized treatment strategies and improve clinical outcomes.…”

Section: Introductionmentioning

confidence: 99%

Nomogram as a predictive model for depression risk in chronic obstructive pulmonary disease

Zhang

Ding

et al. 2022

Preprint

View full text Add to dashboard Cite

Background Depression after chronic obstructive pulmonary disease（COPD）is associated with mortality rates and poor prognosis. This study aimed to develop a nomogram to identify the risk of depression in patients with COPD based on predictors. Methods The Cross sectional study included 494 COPD aged >20 years who were come from the 2005–2008 National Health and Nutrition Examination Survey database. The 345 subjects from the 2005–2008 survey comprised the development group, and the remaining 149 subjects comprised the validation group. The least absolute shrinkage and selection operator (LASSO) binomial regression model was used to select the best predictive variables before further screening of multivariate regression model.The performance of the nomogram was evaluated on the basis of receiver operating characteristic curve(ROC), calibration curve, and clinical decision curve analysis (DCA). Results We reach a decision that there are 10 item,including BMI,Race,Sex,Age,Education,marriage,hypertension,diabetes,CRP,MONO by LASSO regression model.Multivariate regression had selected 4 statistically significant variables for inclusion.as follow:Hypertension,MONO,CRP,Age.hypertension(Odds Ratio[OR],0.836;95%confidence interval [CI],0.206-0.914; P = 0.028),MONO (OR, -2.652; 95% CI, 0.011 to 0.437; P=0.004), CRP (OR,0.238; 95% CI, 1.047 to 1.538; P=0.015) and Age (OR,0.031; 95% CI, 0.947 to 0.992; P=0.009).The AUC area under the curve for the training group was 0.774 whereas the validation group was 0.713, The predictive model was calibrated, and the DCA showed that the proposed nomogram had strong clinical applicability. Conclusion We have developed a simple nomogram to predict depression in COPD individuals based on Nomogram. External validation is needed to further demonstrate its predictive ability in primary care settings.

show abstract

Prevalencia de síntomas depresivos y diagnóstico de sospecha de depresión en pacientes con EPOC

Cited by 6 publications

References 26 publications

Prevalence of Anxiety in COPD Patients. Usefulness of the HADS Test for Establishing the Diagnostic Suspicion of Anxiety Through the Collaboration Between Primary Care, Pulmonology, and Psychiatry Services

Prevalence of Anxiety in COPD Patients. Usefulness of the HADS Test for Establishing the Diagnostic Suspicion of Anxiety Through the Collaboration Between Primary Care, Pulmonology, and Psychiatry Services

Anxiety, Depression and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

Nomogram as a predictive model for depression risk in chronic obstructive pulmonary disease

Contact Info

Product

Resources

About